AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) saw a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 37,249 shares, a decrease of 57.1% from the July 30th total of 86,811 shares. Based on an average daily volume of 23,049 shares, the days-to-cover ratio is currently 1.6 days. Approximately 1.8% of the shares of the company are short sold.
Hedge Funds Weigh In On AdvisorShares Psychedelics ETF
Institutional investors have recently modified their holdings of the business. CIBC Private Wealth Group LLC increased its holdings in shares of AdvisorShares Psychedelics ETF by 18.2% in the 4th quarter. CIBC Private Wealth Group LLC now owns 29,566 shares of the company’s stock valued at $508,000 after acquiring an additional 4,547 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new stake in shares of AdvisorShares Psychedelics ETF in the 3rd quarter worth approximately $475,000. Finally, Vigilare Wealth Management purchased a new position in shares of AdvisorShares Psychedelics ETF during the 2nd quarter worth approximately $212,000.
AdvisorShares Psychedelics ETF Price Performance
Shares of AdvisorShares Psychedelics ETF stock traded down $0.63 on Friday, hitting $25.25. The company’s stock had a trading volume of 27,081 shares, compared to its average volume of 34,162. AdvisorShares Psychedelics ETF has a 1 year low of $15.63 and a 1 year high of $27.02. The firm has a fifty day moving average price of $24.22 and a 200-day moving average price of $20.51.
AdvisorShares Psychedelics ETF Company Profile
The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.
Further Reading
- Five stocks we like better than AdvisorShares Psychedelics ETF
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for AdvisorShares Psychedelics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and related companies with MarketBeat.com's FREE daily email newsletter.
